For more than 80 years, MSD has contributed to the discovery and development of novel medicines and vaccines to combat infectious disease. Today, MSD is a global leader in antimicrobials with a proud heritage, broad portfolio and innovative pipeline.
MSD's Research Laboratories played a central role in the development of antimicrobials
MSD, in collaboration with Rutgers University, developed one of the first methods for mass production of penicillin
MSD markets a number of antibacterial, antifungal, and antiviral products and vaccines for the treatment or prevention of infectious diseases in markets around the globe